Fundacion Rioja Salud

Logrono 18 trials 14 recruiting

18 Registered trials

14 Currently recruiting

Organisation

Fundacion Rioja Salud

Location

Logrono, Spain

Identifier

ORG-100048705

Address

Calle Piqueras 98, 26006, Spain

Departments

7003: Early Phase Clinical Trials
Centro de Investigación Biomédica de La Rioja
CIBIR
Early Phase Clinical Trials
ESP04-0: Oncologia Médica
Medical Oncology
oncology
START Rioja

Clinical trials at this site (18)

Search interface

Pralsetinib (Gavreto) drug drug interaction study in patients with RET+ advanced or metastatic solid tumors. Pending

2025-523158-15-00 Patients with advanced or metastatic solid tumors 11
DB-1311 in Combination with BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors Pending

2025-523895-22-00 Non-small cell lung cancer (NSCLC) 4
Study to assess the efficacy and safety of Rina-S in participants with non-small cell lung cancer Recruiting

2025-522107-18-00 Locally advanced or metastatic Non-Small Cell Lung Canc 4 2026-05-19
A Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with NSCLC Recruiting

2025-522867-13-00 Non Small Cell Lung Cancer 4 2026-04-27
Testing HLX43 in Advanced Lung Cancer (Non-Small Cell): A Global Safety and Effectiveness Study Recruiting

2025-523803-31-00 Advanced non-small cell lung cancer (NSCLC) 4 2026-04-16
A phase 2 placebo-controlled trial to investigate visugromab in combination with immunochemotherapy (ICT) in first-line treatment of partici… Recruiting

2024-516792-32-01 Metastatic non-squamous non-small cell lung cancer 4 2025-07-18
A Clinical Trial to Assess a New Anti-Cancer Treatment (called DSB2455) Given On Its Own in Patients with Advanced Malignancies Recruiting

2023-508805-26-00 patients with active brain metastases, where the primar 1 2024-10-23
An early phase trial of RPTR-1-201 in Advanced Solid Tumors Recruiting

2025-524010-28-00 Advanced Solid Tumor 7 2026-03-20
A Phase 1-2 Master Protocol to Study Intravenous ATTR-01 in Adult Participants with Select Epithelial Solid Tumours Under Multiple Sub-proto… Recruiting

2024-516722-59-00 Select Epithelial Solid Tumours 7 2026-01-23
A trial to learn how safe AZD5335 is and if a drug called itraconazole changes how AZD5335 moves through the body over time in adults with o… Recruiting

2025-522731-34-00 Ovarian cancer Primary peritoneal cancer Fallopian tube 3 2026-01-23
A phase 2 placebo-controlled trial to investigate visugromab and nivolumab with or without docetaxel in second-line treatment of participant… Recruiting

2024-516794-70-00 Metastatic non-squamous non-small cell lung cancer 4 2025-11-03
A Phase 1/2, Multicenter, Open Label, Dose Escalation and Dose Expansion Study of JK06, a 5T4 Antibody Drug Conjugate, in Patients with Unre… Recruiting

2024-512421-92-00 Unresectable, Locally Advanced or Metastatic Cancer 7 2025-10-14
A Phase 1 Study Evaluating the Safety, Tolerability, and Efficacy of BL-B01D1 in Subjects with Metastatic or Unresectable Non-Small Cell Lun… Recruiting

2023-506539-14-00 Oncology 3 2025-05-27
An Open-Label, Multicenter, Multi-Arm Phase 1 Study Evaluating the Safety and Pharmacokinetics of ADU-1805 in Adults with Advanced Solid Tum… Recruiting

2022-502757-34-00 Advanced solid tumors 1 2024-08-20
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a p53 Y220C Mutation (PYNNACLE) Recruiting

2023-504251-27-00 Locally Advanced or Metastatic Solid Tumors Harboring a 7 2024-05-27
Study to Evaluate the PK and Safety of Oral Decitabine and Cedazuridine in Cancer Patients with Renal Impairment Recruiting

2024-516291-16-00 Acute myeloid lymphoma (AML), myelodysplastic syndrome 3 2021-10-26
A first-in-human study to learn about how safe BAY 3375968 is, how it moves into, through, and out of the body, and to find its best dose wh… Ended

2023-505594-32-00 Advanced solid tumors 1 2024-02-20
Study to Evaluate the PK and Safety of Oral Decitabine and Cedazuridine in Cancer Patients with Hepatic Impairment Ended

2024-516292-33-00 Myelodysplastic syndrome (MDS) 3 2021-10-22